Birdwatch Note
2024-10-01 05:55:37 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
以前、同様の噂が拡散され多数の公開CNで誤謬が指摘された点と同じ主張をしています。 https://twitter.com/bunshun_online/status/1770194261046444448 https://twitter.com/bunshun_online/status/1765882623031640303 https://twitter.com/bunshun_online/status/1765578693311914189 コロナワクチン副作用報告で多数の研究が有るという話は大部分、症例報告の事で、適切な対照を置かない研究は一般に科学的根拠がない、とされる話です。 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/series/kenkyu/201905/560545.html 次に報告が多数あるとの疾患は、頭痛、心筋炎、リンパ節腫大、アナフィラキシーのように当局より以前より周知されている公知のリスク、副反応であったり↓ https://www.cov19-vaccine.mhlw.go.jp/qa/0002.html ギランバレーや血栓症は日本で使用されてないベクターワクチンでのみメタ解析で未接種より高リスクな事が同定された疾患である事に注意が必要です https://link.springer.com/article/10.1007/s00415-024-12186-7 (下記3.4.2) https://www.mdpi.com/2076-393X/10/4/596
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1840971529510650100
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1840993955770745058
- noteId - 1840993955770745058
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1727762137726
- tweetId - 1840971529510650100
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 以前、同様の噂が拡散され多数の公開CNで誤謬が指摘された点と同じ主張をしています。 https://twitter.com/bunshun_online/status/1770194261046444448 https://twitter.com/bunshun_online/status/1765882623031640303 https://twitter.com/bunshun_online/status/1765578693311914189 コロナワクチン副作用報告で多数の研究が有るという話は大部分、症例報告の事で、適切な対照を置かない研究は一般に科学的根拠がない、とされる話です。 https://medical.nikkeibp.co.jp/leaf/all/cancernavi/series/kenkyu/201905/560545.html 次に報告が多数あるとの疾患は、頭痛、心筋炎、リンパ節腫大、アナフィラキシーのように当局より以前より周知されている公知のリスク、副反応であったり↓ https://www.cov19-vaccine.mhlw.go.jp/qa/0002.html ギランバレーや血栓症は日本で使用されてないベクターワクチンでのみメタ解析で未接種より高リスクな事が同定された疾患である事に注意が必要です https://link.springer.com/article/10.1007/s00415-024-12186-7 (下記3.4.2) https://www.mdpi.com/2076-393X/10/4/596
Note Ratings
| rated at | rated by | |
| 2024-10-02 16:36:30 -0500 | Rating Details | |
| 2024-10-02 05:42:09 -0500 | Rating Details | |
| 2024-10-01 23:23:27 -0500 | Rating Details | |
| 2024-10-01 21:47:05 -0500 | Rating Details | |
| 2024-10-01 21:20:37 -0500 | Rating Details | |
| 2024-10-01 20:07:42 -0500 | Rating Details | |
| 2024-10-01 12:29:53 -0500 | Rating Details | |
| 2024-10-01 11:37:15 -0500 | Rating Details | |
| 2024-10-01 11:11:14 -0500 | Rating Details | |
| 2024-10-01 10:05:17 -0500 | Rating Details | |
| 2024-10-01 09:48:31 -0500 | Rating Details | |
| 2024-10-01 09:36:43 -0500 | Rating Details | |
| 2024-10-01 09:19:32 -0500 | Rating Details | |
| 2024-10-01 08:30:23 -0500 | Rating Details | |
| 2024-10-01 07:57:00 -0500 | Rating Details | |
| 2024-10-01 06:47:37 -0500 | Rating Details | |
| 2024-10-01 06:23:15 -0500 | Rating Details | |
| 2024-10-01 06:20:19 -0500 | Rating Details | |
| 2024-10-01 05:40:52 -0500 | Rating Details | |
| 2024-10-01 05:33:24 -0500 | Rating Details | |
| 2024-10-01 05:26:06 -0500 | Rating Details | |
| 2024-10-01 05:08:56 -0500 | Rating Details | |
| 2024-10-01 04:54:23 -0500 | Rating Details | |
| 2024-10-01 04:37:03 -0500 | Rating Details | |
| 2024-10-01 04:27:27 -0500 | Rating Details | |
| 2024-10-01 04:24:42 -0500 | Rating Details | |
| 2024-10-01 04:13:46 -0500 | Rating Details | |
| 2024-10-01 03:58:17 -0500 | Rating Details | |
| 2024-10-01 03:49:34 -0500 | Rating Details | |
| 2024-10-01 03:43:11 -0500 | Rating Details | |
| 2024-10-01 03:30:16 -0500 | Rating Details | |
| 2024-10-01 03:25:32 -0500 | Rating Details | |
| 2024-10-01 03:12:09 -0500 | Rating Details | |
| 2024-10-01 03:08:09 -0500 | Rating Details | |
| 2024-10-01 03:04:51 -0500 | Rating Details | |
| 2024-10-01 03:00:46 -0500 | Rating Details | |
| 2024-10-01 02:54:47 -0500 | Rating Details | |
| 2024-10-01 02:48:30 -0500 | Rating Details | |
| 2024-10-01 02:47:00 -0500 | Rating Details | |
| 2024-10-01 02:45:32 -0500 | Rating Details | |
| 2024-10-01 02:43:09 -0500 | Rating Details | |
| 2024-10-01 02:36:31 -0500 | Rating Details | |
| 2024-10-01 02:26:15 -0500 | Rating Details | |
| 2024-10-01 02:19:54 -0500 | Rating Details | |
| 2024-10-01 02:19:36 -0500 | Rating Details | |
| 2024-10-01 02:13:03 -0500 | Rating Details | |
| 2024-10-01 02:10:40 -0500 | Rating Details | |
| 2024-10-01 02:08:42 -0500 | Rating Details | |
| 2024-10-01 01:57:41 -0500 | Rating Details | |
| 2024-10-01 01:50:56 -0500 | Rating Details | |
| 2024-10-01 01:41:31 -0500 | Rating Details | |
| 2024-10-01 01:28:14 -0500 | Rating Details | |
| 2024-10-01 01:25:26 -0500 | Rating Details | |
| 2024-10-01 01:23:47 -0500 | Rating Details | |
| 2024-10-01 01:20:25 -0500 | Rating Details | |
| 2024-10-01 01:13:41 -0500 | Rating Details | |
| 2024-10-01 01:05:16 -0500 | Rating Details | |
| 2024-10-01 15:53:30 -0500 | Rating Details | |
| 2024-10-01 07:45:18 -0500 | Rating Details | |
| 2024-10-01 07:15:46 -0500 | Rating Details | |
| 2024-10-01 05:33:03 -0500 | Rating Details | |
| 2024-10-01 04:35:15 -0500 | Rating Details | |
| 2024-10-01 04:27:14 -0500 | Rating Details | |
| 2024-10-01 04:18:16 -0500 | Rating Details | |
| 2024-10-01 04:12:28 -0500 | Rating Details | |
| 2024-10-01 04:11:20 -0500 | Rating Details | |
| 2024-10-01 02:49:04 -0500 | Rating Details | |
| 2024-10-01 02:41:33 -0500 | Rating Details | |
| 2024-10-01 02:36:28 -0500 | Rating Details | |
| 2024-10-01 02:09:02 -0500 | Rating Details | |
| 2024-10-01 02:08:58 -0500 | Rating Details | |
| 2024-10-01 01:57:18 -0500 | Rating Details | |
| 2024-10-01 01:55:50 -0500 | Rating Details | |
| 2024-10-01 01:49:44 -0500 | Rating Details | |
| 2024-10-01 01:19:07 -0500 | Rating Details | |
| 2024-10-09 04:18:49 -0500 | Rating Details | |
| 2024-10-08 05:14:31 -0500 | Rating Details | |
| 2024-10-01 04:47:21 -0500 | Rating Details | |
| 2024-10-01 04:39:22 -0500 | Rating Details | |
| 2024-10-01 03:12:36 -0500 | Rating Details | |
| 2024-10-01 01:46:02 -0500 | Rating Details | |
| 2024-10-01 14:07:04 -0500 | Rating Details | |
| 2024-10-01 08:24:30 -0500 | Rating Details | |
| 2024-10-01 07:04:02 -0500 | Rating Details | |
| 2024-10-01 05:36:32 -0500 | Rating Details | |
| 2024-10-01 02:22:49 -0500 | Rating Details | |
| 2024-10-13 02:37:04 -0500 | Rating Details |